The inTank^TM BWTS process ensures disinfection of ballast water tanks and piping through the application of a targeted CT, which is the product of disinfection Concentration (in milligrams per liter, mg/L) and disinfection contact Time (in hours) measured as total residual oxidant (TRO). The system works by circulating each ballast tank, injecting disinfectant, until the target dose is reached. This is all done while the vessel is underway, thus eliminating the risk of interrupting port operations.

Other Applications

The Envirocleanse mission is to provide the world with a sustainable biocide. The patent-pending technology behind Envirocleanse was brought to the forefront by Dr. Phil Bellan as a means to fight infection in wounds. In late 2015, Charter Brokerage, a BERKSHIRE HATHAWAY unit, bought Envirocleanse to increase Envirocleanse’s size and scope. Since its purchase, the company has begun to expand into the oil-and-gas, medical, food and food distribution, and the ballast-water-treatment industries. The flagship of Envirocleanse is the FDA-approved and EPA-registered disinfectant known as Envirocleanse-A (the A stands for “Anolite”). The Anolite solution is hypochlorous acid (HOCL), a nontoxic, non-corrosive biodegradable disinfectant. Envirocleanse has teamed up with Glosten Marine Engineering to create the only In-Tank Ballast Water Treatment System (BWTS) on the market. Treating the water in the tank provides numerous advantages over all other BWTS currently available. To find out more, please contact one of our listed team members.

Medical Industry

Envirocleanse-A has many useful applications in hospitals, clinics, nursing homes and other medical facilities. It is an extremely effective means of eliminating bacteria, viruses and fungi when used as a topical disinfectant on hard surfaces, such as tables, sinks, floors and other surfaces. Most important, it is completely nontoxic and biodegradable as well as nonflammable.

Independent laboratory testing has shown Envirocleanse-A to be effective in hard-surface disinfection against bacteria and viruses, including the following:

MRSA (staphylococcus)
Norovirus
VRE (vancomysin-resistant enterococcus)
Ecoli H7: 157 [NB: 157?]
H1N1 virus
Salmonella
Listeria
Hepatitis A, B and C

Anolyte Water

Our mission is to provide a superior next-generation disinfectant for commercial and industrial use that is non-toxic and sustainable. The patent-pending technology behind Envirocleanse’s anolyte water was brought to the forefront by Dr. Phil Bellan as a means to fight infection in wounds. In late 2015, Charter Brokerage, a BERKSHIRE HATHAWAY unit, bought Envirocleanse to increase Envirocleanse’s size and scope. Since its purchase, the company has begun to expand into the oil-and-gas, medical, food and food distribution, and the ballast-water-treatment industries. The flagship of Envirocleanse is the FDA-approved and EPA-registered disinfectant known as Envirocleanse-A (the A stands for “Anolyte”). The Anolyte solution is hypochlorous acid (HOCL), a nontoxic, non-corrosive biodegradable disinfectant.

Anolyte Water

Envirocleanse, LLC Downloads

Envirocleanse - Ballast Water Management Systems Brochure

Envirocleanse - Ballast Water Management Systems Brochure 1